Status:
COMPLETED
Increasing the Temporal Window in Individuals With Alcohol Use Disorder
Lead Sponsor:
Virginia Polytechnic Institute and State University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
McMaster University
Conditions:
Alcohol Use Disorder
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
Episodic future thinking (EFT) is based on the new science of prospection, which was first identified in a Science publication in 2007 and refers to pre-experiencing the future by simulation. Consider...
Detailed Description
In study 1, participants will be randomly assigned to experimental or control groups, stratified by AUDIT scores, SES, age and sex. Based on our 8 years of experience recruiting this population, we ex...
Eligibility Criteria
Inclusion
- High-risk or harmful drinking (measured by AUDIT)
- 21-65 years of age
- Desire to quit or cut down on their drinking, but do not have proximate plans to enroll in treatment for AUD during the study period
- Report as one of their top three preferred drinks a beverage appropriate for the alcohol self-administration task (Study 1)
Exclusion
- Moderate to severe DSM-5 criteria for substance-use disorders other than alcohol, nicotine, and/or marijuana
- Current diagnosis of any psychotic disorder
- History of seizure disorders or traumatic brain injury
- Contraindication for participation in the self-administration (Study 1) or MRI sessions (Studies 1 and 2)
- Current pregnancy or lactation.
Key Trial Info
Start Date :
November 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04125238
Start Date
November 13 2020
End Date
September 30 2024
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States, 24016